Polymorph Applications: The Mexican Approach.
Mondaq Business Briefing › Nbr. 2009, January 2009
Linked as:
Extract
Polymorph Applications: The Mexican Approach.
In the summer of 1998, Abbot Laboratories was forced to remove from the market a first crystalline form of its medicament ritonavir, a peptidomimetic drug used to treat HIV-1 infection, in favor of a second molecular form, or polymorph, which had different dissolution properties. The fir...
See the full content of this document
Sponsored links
